With each point increase in the HADS depression subscale (indicating higher levels of depressive mood) NPAD-d scores increased by 2.16 points (95% confidence intervals (CI) 1.74 2.57).
Results: Patients with higher levels of depressive symptoms used rehabilitation services less efficiently than those with lower symptom levels but did not have longer LOSs.
Despite these limitations, some reports have suggested that symptoms of psychological distress may predict individual differences in pain treatment-related outcomes (e.g., higher levels of depressive and anxious symptomatology are associated with greater pain and disability after treatment).
Among studies that assessed depressive symptoms using the EPDS, higher levels of depressive symptoms at pre-treatment were associated with smaller differences in depressive symptoms by 6 months postpartum.
After the researchers controlled for general stress (financial problems, for instance, or traumatic events or chronic illnesses), the most significant effects of discrimination were higher levels of depressive symptoms and lower self-rated health.
Higher scores indicate higher levels of depressive symptoms [18].
Patients who were deemed nonresponders to treatment had higher levels of depressive symptoms at pretreatment than those who responded.
In all countries, more deficits and more negative social interactions are associated with higher levels of depressive symptoms.
Those who were only victims had higher levels of depressive disorders, anxiety disorders, generalized anxiety, panic disorder, and agoraphobia.
Compared with other nonmedical users of ADHD medication, those reporting attention difficulties had lower GPAs, greater academic concerns, and higher levels of depressive symptoms.
Higher levels of depressive symptoms were related to more severe social anxiety overall, and to less change in social anxiety symptoms over the course of the study.
